NEJM (The New England Journal of Medicine)
All the latest articles published on New England Journal of Medicine before going in to print. And all articles from NEJM Evidence Journal. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Show more📈 Analytical overview of Telegram channel NEJM (The New England Journal of Medicine)
Channel NEJM (The New England Journal of Medicine) (@the_nejm) in the English language segment is an active participant. Currently, the community unites 27 257 subscribers, ranking 757 in the Medicine category and 1 395 in the USA region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 27 257 subscribers.
According to the latest data from 06 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 307 over the last 30 days and by 4 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 8.43%. Within the first 24 hours after publication, content typically collects 2.74% reactions from the total number of subscribers.
- Post reach: On average, each post receives 2 296 views. Within the first day, a publication typically gains 747 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 2.
- Thematic interests: Content is focused on key topics such as medicine, journal, print, cancer, patient.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“All the latest articles published on New England Journal of Medicine before going in to print.
And all articles from NEJM Evidence Journal.
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicin...”
Thanks to the high frequency of updates (latest data received on 07 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Data loading in progress...
| Date | Subscriber Growth | Mentions | Channels | |
| 08 September | +6 | |||
| 07 September | +6 | |||
| 06 September | +4 | |||
| 05 September | +13 | |||
| 04 September | +6 | |||
| 03 September | +12 | |||
| 02 September | +5 | |||
| 01 September | +5 |
| 2 | The Long Shadow of Bedlam
https://www.nejm.org/doi/full/10.1056/NEJMp2600529?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 937 |
| 3 | AI-Based Translation of Discharge Instructions — Aligning Policy with Practice
https://www.nejm.org/doi/full/10.1056/NEJMp2603777?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 940 |
| 4 | The Future of the USPSTF and Evidence-Based Recommendations
https://www.nejm.org/doi/full/10.1056/NEJMp2607441?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 916 |
| 5 | When Fear Became the Barrier to Care — Lessons of a Clinical Rapid Response during Operation Metro Surge
https://www.nejm.org/doi/full/10.1056/NEJMp2607981?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 852 |
| 6 | Infigratinib in Achondroplasia — A Potentially Giant Step Forward
https://www.nejm.org/doi/full/10.1056/NEJMe2609749?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 919-920, September 3, 2026. | 1 538 |
| 7 | Fluid Resuscitation in Patients with Sepsis — For Whom the Balance Tolls
https://www.nejm.org/doi/full/10.1056/NEJMe2609856?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 921-922, September 3, 2026. | 1 426 |
| 8 | Case 20-2026: A 38-Year-Old Man with Abdominal Pain
https://www.nejm.org/doi/full/10.1056/NEJMx260023?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 936-936, September 3, 2026. | 1 276 |
| 9 | Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML
https://www.nejm.org/doi/full/10.1056/NEJMe2607967?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 917-919, September 3, 2026. | 1 197 |
| 10 | A Zoonotic Orthonairovirus from Febrile Patients in China
https://www.nejm.org/doi/full/10.1056/NEJMc2602496?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 929-931, September 3, 2026. | 1 048 |
| 11 | Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
https://www.nejm.org/doi/full/10.1056/NEJMc2603114?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 926-929, September 3, 2026. | 988 |
| 12 | Childhood Vaccine Hesitancy
https://www.nejm.org/doi/full/10.1056/NEJMc2608837?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 933-934, September 3, 2026. | 991 |
| 13 | More on Causes of Death among Children and Adolescents in the United States
https://www.nejm.org/doi/full/10.1056/NEJMc2608518?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 934-936, September 3, 2026. | 994 |
| 14 | Telitacicept for IgA Nephropathy
https://www.nejm.org/doi/full/10.1056/NEJMc2608517?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 931-933, September 3, 2026. | 911 |
| 15 | Physical Examination for Asymptomatic Adults
https://www.nejm.org/doi/full/10.1056/NEJMclde2515158?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, Page 923-925, September 3, 2026. | 931 |
| 16 | Acro-Osteolysis
https://www.nejm.org/doi/full/10.1056/NEJMicm2605116?af=R&rss=currentIssue
New England Journal of Medicine, Volume 395, Issue 9, September 3, 2026. | 933 |
| 17 | NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
http://www.nejm.org/doi/full/10.1056/NEJMp2608826
Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835. | 1 370 |
| 18 | NEJM This Week — September 3, 2026
http://www.nejm.org/toc/nejm/395/9
This week, we feature new research on acute myeloid leukemia, achondroplasia, pediatric septic shock, and RAS-mutant lung cancer. We also review the evaluation and management of pulmonary nodules and follow a diagnostic case of recurrent fractures. Perspectives explore reproductive health care, the human–animal bond in health care access, and on creating space for patients’ voices in clinical decision making. | 1 252 |
| 19 | Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism
https://www.nejm.org/doi/full/10.1056/NEJMoa2608012?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 1 586 |
| 20 | Immediate Ambulatory Electrocardiographic Monitoring in Syncope
https://www.nejm.org/doi/full/10.1056/NEJMoa2605812?af=R&rss=currentIssue
New England Journal of Medicine, Ahead of Print. | 1 858 |
